Reproductive Endocrinology
A section of Endocrines (ISSN 2673-396X).
Section Information
This section welcomes researchers investigating the aetiology, pathogenesis, and clinical aspects of reproductive endocrinology across the life course, including both female and male reproductive endocrinology and sexual health, with relevance to systemic endocrine and metabolic regulation. We prioritise work spanning the prevention, diagnosis, and monitoring of reproductive endocrine function and fertility-related disorders, including pubertal development, gonadal dysfunction, ovulatory and menstrual disorders, PCOS, endocrine–metabolic correlates of endometriosis, hypogonadism, sexual dysfunction, infertility, male reproductive disorders and spermatogenic dysfunction, recurrent pregnancy loss, placental and pregnancy-related endocrinology, and endocrine sequelae of cancer therapy or systemic disease.
Priority areas include genetic and epigenetic determinants, multi-omics profiles, hypothalamic–pituitary–gonadal and hypothalamic–pituitary–placental signalling, gametogenesis and reproductive potential across sexes, steroidogenesis and receptor biology, immuno-endocrine and metabolic crosstalk, microbiome and environmental influences (including endocrine disruptors), developmental origins and intergenerational effects, and the cellular and molecular circuits governing reproductive function and sexual health.
We also welcome research on innovative and evidence-based interventions, including lifestyle and preventive strategies, endocrine pharmacotherapy, and fertility-related medical management. This includes hormonal and non-hormonal therapeutics, peptides and small molecules, antibodies, RNA- or gene-editing tools, assisted reproductive technologies, digital health and behavioural strategies, and fertility preservation. Submissions advancing precision medicine—novel biomarkers, molecular endotyping, head-to-head comparisons, and real-world effectiveness studies—and those addressing health equity in underserved populations are particularly encouraged.
Spanning basic, translational, and clinical research, this section aims to accelerate effective and equitable solutions to global reproductive health challenges.
